134 related articles for article (PubMed ID: 6390794)
1. Carbamazepine levels in breast milk.
Froescher W; Eichelbaum M; Niesen M; Dietrich K; Rausch P
Ther Drug Monit; 1984; 6(3):266-71. PubMed ID: 6390794
[TBL] [Abstract][Full Text] [Related]
2. Carbamazepine and carbamazepine-10,11- epoxide during pregnancy and postnatal period in epileptic mother and their nursed infants: pharmacokinetics and clinical effects.
Kuhnz W; Jäger-Roman E; Rating D; Deichl A; Kunze J; Helge H; Nau H
Pediatr Pharmacol (New York); 1983; 3(3-4):199-208. PubMed ID: 6677873
[TBL] [Abstract][Full Text] [Related]
3. Monitoring of carbamazepine and carbamazepine 10,11-epoxide in breast milk and plasma by high-performance liquid chromatography.
Shimoyama R; Ohkubo T; Sugawara K
Ann Clin Biochem; 2000 Mar; 37 ( Pt 2)():210-5. PubMed ID: 10735366
[TBL] [Abstract][Full Text] [Related]
4. Factors influencing simultaneous concentrations of total and free carbamazepine and carbamazepine-10, 11-epoxide in serum of children with epilepsy.
Elyas AA; Patsalos PN; Agbato OA; Brett EM; Lascelles PT
Ther Drug Monit; 1986; 8(3):288-92. PubMed ID: 3750372
[TBL] [Abstract][Full Text] [Related]
5. Value of saliva samples in monitoring carbamazepine concentrations in epileptic patients.
Kristensen O; Larsen HF
Acta Neurol Scand; 1980 Jun; 61(6):344-50. PubMed ID: 6998249
[TBL] [Abstract][Full Text] [Related]
6. Intradose and circadian variation in circulating carbamazepine and its epoxide in epileptic patients: a consequence of autoinduction of metabolism.
Macphee GJ; Butler E; Brodie MJ
Epilepsia; 1987; 28(3):286-94. PubMed ID: 3582293
[TBL] [Abstract][Full Text] [Related]
7. A comprehensive study of the relation between serum concentrations, concentration ratios, and level/dose ratios of carbamazepine and its metabolites with age, weight, dose, and clearances in epileptic children.
Liu H; Delgado MR
Epilepsia; 1994; 35(6):1221-9. PubMed ID: 7988515
[TBL] [Abstract][Full Text] [Related]
8. Influence of sex, age, weight, and carbamazepine dose on serum concentrations, concentration ratios, and level/dose ratios of carbamazepine and its metabolites.
Liu H; Delgado MR
Ther Drug Monit; 1994 Oct; 16(5):469-76. PubMed ID: 7846744
[TBL] [Abstract][Full Text] [Related]
9. Carbamazepine drug interactions: the influence of concurrent drug therapy on serum concentrations of carbamazepine and its epoxide metabolite.
Wang RB; Liu LT; Yiu CH; Chang TY
Zhonghua Yi Xue Za Zhi (Taipei); 1990 Apr; 45(4):222-32. PubMed ID: 2168269
[TBL] [Abstract][Full Text] [Related]
10. Carbamazepine 10, 11 epoxide concentrations in epileptics on carbamazepine alone and in combination with other anticonvulsants.
Brodie MJ; Forrest G; Rapeport WG
Br J Clin Pharmacol; 1983 Dec; 16(6):747-9. PubMed ID: 6661364
[TBL] [Abstract][Full Text] [Related]
11. Daily variations in steady-state plasma concentrations of carbamazepine and its metabolites in epileptic children.
Hartley R; Forsythe WI; McLain B; Ng PC; Lucock MD
Clin Pharmacokinet; 1991 Mar; 20(3):237-46. PubMed ID: 2025982
[TBL] [Abstract][Full Text] [Related]
12. Carbamazepine and carbamazepine-10,11-epoxide serum concentrations in epileptic children.
Furlanut M; Montanari G; Bonin P; Casara GL
J Pediatr; 1985 Mar; 106(3):491-5. PubMed ID: 3973787
[TBL] [Abstract][Full Text] [Related]
13. Relationship of intraindividual dose to plasma concentration of carbamazepine: indication of dose-dependent induction of metabolism.
Tomson T; Svensson JO; Hilton-Brown P
Ther Drug Monit; 1989 Sep; 11(5):533-9. PubMed ID: 2815227
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of carbamazepine and carbamazepine-epoxide protein binding in patients undergoing epilepsy surgery.
Gidal BE; Spencer NW; Maly MM; Pitterle ME
Epilepsia; 1996 Apr; 37(4):381-5. PubMed ID: 8603645
[TBL] [Abstract][Full Text] [Related]
15. Chiral separation of 10,11-dihydro-10, 11-trans-dihydroxycarbamazepine, a metabolite of carbamazepine with two asymmetric carbons, in human serum.
Eto S; Tanaka N; Noda H; Noda A
J Chromatogr B Biomed Appl; 1996 Mar; 677(2):325-30. PubMed ID: 8704937
[TBL] [Abstract][Full Text] [Related]
16. Lateral gaze nystagmus in carbamazepine-treated epileptic patients: correlation with total and free plasma concentrations of parent drug and its 10,11-epoxide metabolite.
Riva R; Contin M; Albani F; Perucca E; Ambrosetto G; Procaccianti G; Santucci M; Baruzzi A
Ther Drug Monit; 1985; 7(3):277-82. PubMed ID: 4049464
[TBL] [Abstract][Full Text] [Related]
17. Kinetics of carbamazepine and its 10,11-epoxide metabolite in children.
Rane A; Höjer B; Wilson JT
Clin Pharmacol Ther; 1976 Mar; 19(3):276-83. PubMed ID: 1261166
[TBL] [Abstract][Full Text] [Related]
18. Free and total serum concentrations of carbamazepine and carbamazepine-10,11-epoxide in infancy and childhood.
Riva R; Contin M; Albani F; Perucca E; Lamontanara G; Baruzzi A
Epilepsia; 1985; 26(4):320-2. PubMed ID: 4006891
[TBL] [Abstract][Full Text] [Related]
19. Carbamazepine-10,11-diol steady-state serum levels and renal excretion during carbamazepine therapy in adults and children.
Bourgeois BF; Wad N
Ther Drug Monit; 1984; 6(3):259-65. PubMed ID: 6506133
[TBL] [Abstract][Full Text] [Related]
20. The pharmacology of chewable versus regular carbamazepine in chronically treated children with epilepsy.
Camfield P; Hwang P; Camfield C; Fraser A; Soldin S; al-Quadah AK
Can J Neurol Sci; 1992 May; 19(2):204-7. PubMed ID: 1623447
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
